Kaoru Abiko
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Immunology top 1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Ovarian cancer diagnosis and treatment 37
-
- Endometrial and Cervical Cancer Treatments 25
- Uterine Myomas and Treatments 13
- Co-authors
- Tsukasa BabaJunzo HamanishiNoriomi MatsumuraMasaki MandaiIkuo KonishiKen YamaguchiRyusuke MurakamiNaoki Horikawa
- Journals
- Journal of Gynecologic Oncology (6 papers)Gynecologic Oncology (5 papers)International Journal of Clinical Oncology (5 papers)Clinical Cancer Research (4 papers)Pathology International (4 papers)
- Partner nations
- JapanUnited StatesEgypt
In The Last Decade
Kaoru Abiko
98 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 2.4k
- Immunology 1.8k
- Reproductive Medicine 697
- Obstetrics and Gynecology 326
- Cancer Research 557
Countries citing papers authored by Kaoru Abiko
This map shows the geographic impact of Kaoru Abiko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaoru Abiko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaoru Abiko more than expected).
Fields of papers citing papers by Kaoru Abiko
This network shows the impact of papers produced by Kaoru Abiko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaoru Abiko. The network helps show where Kaoru Abiko may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kaoru Abiko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 8 | |
| 4 | 2022 | 10 | |
| 5 | 2022 | 23 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 1 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 2 | |
| 10 | 2019 | 4 | |
| 11 | 2019 | 10 | |
| 12 | 2018 | 35 | |
| 13 | 2017 | 4 | |
| 14 | 2017 | 12 | |
| 15 | 2017 | 8 | |
| 16 | 2016 | 228 | |
| 17 | 2016 | 9 | |
| 18 | 癌治療におけるPD‐1/PD‐L1阻害:展望と問題 | 2016 | 1 |
| 19 | Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer Hit paper breakdown → | 2015 | 437 |
| 20 | 2013 | 187 |
About Kaoru Abiko
Kaoru Abiko is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Horticulture and Immunology, having authored 102 papers that have together received 4.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (37 papers), Endometrial and Cervical Cancer Treatments (25 papers), Cancer Immunotherapy and Biomarkers (20 papers), Uterine Myomas and Treatments (13 papers), Immune Cell Function and Interaction (12 papers), Immune cells in cancer (10 papers), Cervical Cancer and HPV Research (7 papers) and Sarcoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (2.4k citations), Immunology (1.8k citations), Reproductive Medicine (697 citations), Obstetrics and Gynecology (326 citations) and Cancer Research (557 citations). Kaoru Abiko has collaborated with scholars based in Japan, United States and Egypt. Frequent co-authors include Tsukasa Baba, Junzo Hamanishi, Noriomi Matsumura, Masaki Mandai, Ikuo Konishi, Ken Yamaguchi, Ryusuke Murakami, Naoki Horikawa, Yumiko Yoshioka and Yuko Hosoe. Their work appears in journals such as Journal of Gynecologic Oncology, Gynecologic Oncology, International Journal of Clinical Oncology, Clinical Cancer Research and Pathology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.